Cardiac Biomarkers Market

SKU: DMMD256 | Last Updated On: Oct 13 2021 | No. of Pages: 180 | Available Formats

> Global Cardiac Biomarkers Market Expected to reach a high CAGR of 18% By 2028: DataM Intelligence

Global Cardiac Biomarkers Market is segmented By Cardiac Biomarker Tests (Troponin, Creatine kinase, Myoglobin, Galectin-3, Other Biomarker Tests), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Angina, others), By Testing Location (Laboratory Testing, Point of Care Testing), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

THe Global Cardiac Biomarkers Market is expected to grow at a CAGR of 18% during the forecast period (2021-2028)  

  • The market growth is driven by several factors such as rising awareness towards the personalized medicine and increasing commercialization of novel biomarkers is majorly driving the cardiac biomarkers market. The growth of the market is being hindered as the market has reached its saturation level with continuous investments.
  • The major players of global Cardiac Biomarkers market include Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Alere Inc., Randox Laboratories, Roche Diagnostics Corporation, Becton Dickinson And Co., Bio-Rad Laboratories, Thermo Fisher Scientific, BioMerieux.
  • Cardiac Biomarkers Market

Market Segmentation

  • The Global Cardiac Biomarkers market is segmented by Cardiac Biomarkers Tests such as Troponin (I or T), Creatine kinase (CK), Myoglobin, Galectin-3, Other Biomarker Tests (hs-CRP, BNP (or NT-proBNP)). Troponin (I or T) is themarket segment occupying the highest market share of global cardiac biomarkers market because of remarkable specificity and its ability to detect cardiac events of Acute Coronary Syndrome (ACS) more accurately.
  • By Applications, the market is segmented into Acute Coronary Syndrome, Congestive Heart Failure, Myocardial infarction (MI), Angina, and Others. Myocardial Infarction (MI) is the largest segment of applications of global Cardiac Biomarkers as Myocardial infarction (MI) is the most common type of heart disease and the leading cause of cardiac-related death worldwide. Biomarkers play a crucial role in diagnosis, risk stratification, and clinical decisions in determining early stages symptoms and curing the diseases.
  • By Testing Location, the market is segmented into Laboratory Testing and Point of Care Testing Locations where Point of Care is the fastest growing segment due to new innovative cardiovascular diagnostic technologies improving the patient care. They provide high-quality biomarker measurements for different cardiac diseases.
  • Geographically, the market is segmented into North America, South America, Europe, Asia-Pacific, and RoW. North America is leading the global Cardiac Biomarkers market due to rising awareness towards health diseases and advancement in technology related to several testing equipment.
  • In the US, there were approximately 1.5 million cases of Myocardial Infarction(MI). Out of them, some require urgent evaluation for possible cardiac ischemia that consume substantial US healthcare resources. But from 1999 to 2009, due to substantial improvements in the management of the patients, the relative rate of death related to CVD (Cardiovascular Diseases) declined by 31%. However, in 2009, CVD still accounted for approx. 31% (787,931) of all 2,437,163 deaths, or 1 of every 3 deaths in the US.

"The report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles".

Why purchase the report?

  • Visualize the composition of Global Cardiac Biomarkers market across each indication, in terms of type and applications, highlighting the key commercial assets and players.
  • Identify commercial opportunities in Global Cardiac Biomarkers by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Global Cardiac Biomarkers market level 4/5 segmentation
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  • Product mapping in excel for key Global Cardiac Biomarkers products of all major market players.

Who can benefit from this report?

  • Raw Material Suppliers/ Buyers

  • Product Suppliers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers

 

Related Reports

Cancer Biomarkers Market

Renal Biomarkers Market

 

 

 

 

Table of Contents

Chapter 1. Methodology and Scope

1.1 Research methodology

1.2 Scope of the Report

Chapter 2 Cardiac Biomarkers Market-Trends

2.1 Key Trends & Developments

Chapter 3 Cardiac Biomarkers Market-Industry Analysis

3.1 Industry Impact Factors (Drivers & Restraints)

3.2 Competitive Intensity- Porter 5 Forces

3.3 Regulatory Analysis

Chapter 4 Cardiac Biomarkers Market- Product Analysis

4.1. By Cardiac Biomarker Tests

4.1.1 Troponin (I or T)

4.1.2 Creatine kinase (CK)

4.1.3 Myoglobin

4.1.4 Galectin-3

4.1.5 Other Biomarker Tests

4.1.5.1 hs-CRP

4.1.5.2 BNP (or NT-proBNP)

4.2. By Applications

4.2.1 Acute Coronary Syndrome

4.2.2 Congestive Heart Failure

4.2.3 Myocardial infarction (MI)

4.2.4 Angina

4.2.5 Other

4.3 By Testing Location

4.3.1 Laboratory Testing

4.3.2 Point of Care Testing

Chapter 5  Cardiac Biomarkers Market- Geographical Analysis

5.1. Asia Pacific

5.1.1. China

5.1.2. Japan

5.1.3. India

5.1.4. Australia

5.1.5. Rest of Asia Pacific

5.2. Europe

5.2.1. Germany

5.2.2. France

5.2.3. The UK

5.2.4. Italy

5.2.5. Spain

5.2.6. Rest of Europe

5.3. North America

5.3.1. The USA

5.3.2. Canada

5.3.3. Mexico

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. RoW

Chapter 6 Cardiac Biomarkers Market – Competitive Landscape

6.1 Market Share Analysis

6.2 Key Strategies

6.3 Product Benchmarking

Chapter 7 Cardiac Biomarkers Market – Company Profiles

7.1. Siemens Healthcare

7.2 Abbott laboratories

7.3 Beckman Coulter

7.4 Alere Inc.

7.5 Randox laboratories

7.6 Roche Diagnostics Corporation

7.7 Becton Dickinson And Co.

7.8 Bio-Rad Laboratories

7.9 Thermo Fisher Scientific

7.10 BioMerieux

Chapter 8  Cardiac Biomarkers Market – Appendix

8.1 Sources

8.2 List of Tables

8.3 Expert Panel Validation

8.4 Disclaimer

8.5 Contact Us

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest